Optimizing Cigna Kevzara Prior Authorization Workflows

Navigating **Cigna Kevzara prior authorization** requires precision across medical and pharmacy benefits. Klivira streamlines this complex process, integrating with Cigna Healthcare's established submission channels.

For revenue cycle directors and prior authorization teams, managing high-volume specialty drug PAs like Kevzara can strain resources. Understanding the specific requirements of payers like Cigna Healthcare is critical to minimizing denials and accelerating patient access. This page details the pathways for securing authorization for Kevzara under Cigna plans.

Understanding Kevzara and Cigna Coverage

Kevzara (sarilumab) is a targeted biologic for rheumatoid arthritis and other inflammatory conditions. As a specialty medication, its authorization process under Cigna Healthcare involves specific clinical criteria and submission pathways, often routed through Evernorth's specialty services.

Cigna Healthcare Prior Authorization Channels for Kevzara

Cigna Healthcare differentiates between medical and pharmacy benefit submissions for specialty drugs. Medical-benefit Kevzara PAs are typically processed through the CignaforHCP.com provider portal or via X12 278 transactions. Pharmacy-benefit Kevzara PAs, including those for self-administered injectables, are managed by Express Scripts.

Key Submission Pathways for Kevzara PA with Cigna

**Medical Benefit:** Utilize CignaforHCP.com for direct submission and document uploads, or leverage X12 278 for electronic data interchange via clearinghouses.
**Pharmacy Benefit (Express Scripts):** Submissions route through Express Scripts' provider PA system, with ePA options available via CoverMyMeds and Surescripts for prescriber-initiated requests.
**Specialty Pharmacy (Accredo):** For specialty injectables, Accredo, an Evernorth company, manages dedicated PA workflows under the pharmacy benefit.
**Policy Review:** Consult Cigna Healthcare's public provider site for current medical-necessity guidelines and coverage policies specific to Kevzara.

Navigating Cigna's Utilization Management Policies for Specialty Biologics

Cigna Healthcare publishes detailed coverage policies outlining clinical criteria for specialty biologics like Kevzara. These policies specify indications, contraindications, and often require documentation of conservative care trials or step therapy adherence. It is essential to reference the specific policy number and effective date from Cigna's public provider site.

Common Denial Reasons and Appeal Pathways for Kevzara with Cigna

Denials for Kevzara PA often stem from insufficient documentation, failure to meet medical necessity criteria, or non-adherence to step therapy protocols. Cigna Healthcare communicates denials via X12 277/835 and through the CignaforHCP portal. The appeal process, including peer-to-peer review, is detailed in the Cigna Provider Manual and on the provider portal, with distinct pathways for commercial and Medicare Advantage plans.

Klivira's Role in Streamlining Cigna Kevzara PAs

Klivira automates the submission and tracking of Cigna Kevzara prior authorizations by integrating directly with CignaforHCP.com and leveraging ePA channels through Express Scripts partners. Our platform ensures accurate data submission, monitors policy updates, and provides real-time status visibility, reducing manual effort and accelerating approval times.

Frequently asked questions

Which Cigna entity handles Kevzara prior authorizations?

For medical-benefit Kevzara, Cigna Healthcare manages prior authorizations. For pharmacy-benefit Kevzara, Evernorth's Express Scripts acts as the PBM, with Accredo handling specialty pharmacy services.

What submission channels are available for Kevzara PA with Cigna?

Medical-benefit submissions can be made via the CignaforHCP.com provider portal or X12 278 transactions. Pharmacy-benefit submissions for Express Scripts utilize their provider PA system, CoverMyMeds, or Surescripts ePA.

Where can I find Cigna's medical necessity criteria for Kevzara?

Cigna Healthcare publishes its coverage policies and medical-necessity guidelines on its public provider website. Always refer to the specific policy number and its effective date for the most current requirements.

Does Cigna follow specific turnaround times for Kevzara PAs?

Cigna Healthcare's PA turnaround times are governed by state-mandated minimums for commercial plans. For Medicare Advantage plans, Cigna is subject to CMS-0057-F, which mandates 72-hour standard and 24-hour expedited timeframes.

What are common reasons for a Kevzara PA denial from Cigna?

Common denial reasons include insufficient clinical documentation, failure to meet Cigna's medical necessity criteria, lack of adherence to required step therapy, or issues related to the site of service.